The Sarah Cannon Research Institute/Tennessee Oncology — Nashville, Tennessee

The Sarah Cannon Research Institute/Tennessee Oncology is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

The Sarah Cannon Research Institute/Tennessee Oncology has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma.

Sponsors: Pfizer, Curis, Inc., Taiho Pharmaceutical Co., Ltd..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Sarah Cannon Research Institute/Tennessee Oncology?

The Sarah Cannon Research Institute/Tennessee Oncology has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Sarah Cannon Research Institute/Tennessee Oncology conducted?

The Sarah Cannon Research Institute/Tennessee Oncology has 5 clinical trials on record, with 2 currently active. Their work covers Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma.

Is The Sarah Cannon Research Institute/Tennessee Oncology accredited by Crixeo Health?

Yes — The Sarah Cannon Research Institute/Tennessee Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Sarah Cannon Research Institute/Tennessee Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.